The COVID-19 virus emerged at the start of 2020, highly infectious and with no immediate vaccine or treatment solutions available.
Associate Professor Sze-Yuan Ooi, and a team of infectious disease and respiratory specialists, worked with the TeleClinical Care team to develop TCC-COVID, an app that allows clinicians to monitor symptoms in COVID-positive patients. This App helps to limit the spread of the virus by supporting those with mild to moderate risk to be cared for at home, while enabling them to respond quickly to those who showed signs of deterioration.
Early in the virus, TCC-COVID was used by a limited number of patients willing to take part in a clinical trial. When the second wave arrived in 2021, the TCC team moved quickly to negotiate with the Therapeutic Goods Association (TGA) to have the App approved for widespread implementation across the South Eastern Sydney LHD.
Related content Read an interview with Dr Kristen Overton who shares her experiences of using TCC-Covid with patients during the pandemic A/Prof Sze-Yuan Ooi discusses the TCC Program and the importance of engaging clinicians. Read the full interview.
